Ketorolac Tromethamine API Market Report – Research, Industry Analysis Reports and Market Demands

Global Ketorolac Tromethamine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ketorolac Tromethamine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ketorolac Tromethamine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Ketorolac Tromethamine Capsules
- 1.4.3 Ketorolac Tromethamine Tablets
- 1.4.4 Ketorolac Tromethamine Injection
- 1.4.5 Others
1.5 Global Ketorolac Tromethamine API Market Size & Forecast
- 1.5.1 Global Ketorolac Tromethamine API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Ketorolac Tromethamine API Sales Quantity (2020-2031)
- 1.5.3 Global Ketorolac Tromethamine API Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Ketorolac Tromethamine API by Manufacturer

3.1 Global Ketorolac Tromethamine API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Ketorolac Tromethamine API Revenue by Manufacturer (2020-2025)
3.3 Global Ketorolac Tromethamine API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Ketorolac Tromethamine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Ketorolac Tromethamine API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Ketorolac Tromethamine API Manufacturer Market Share in 2024
3.5 Ketorolac Tromethamine API Market: Overall Company Footprint Analysis
- 3.5.1 Ketorolac Tromethamine API Market: Region Footprint
- 3.5.2 Ketorolac Tromethamine API Market: Company Product Type Footprint
- 3.5.3 Ketorolac Tromethamine API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Ketorolac Tromethamine API Market Size by Region
- 4.1.1 Global Ketorolac Tromethamine API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Ketorolac Tromethamine API Consumption Value by Region (2020-2031)
- 4.1.3 Global Ketorolac Tromethamine API Average Price by Region (2020-2031)
4.2 North America Ketorolac Tromethamine API Consumption Value (2020-2031)
4.3 Europe Ketorolac Tromethamine API Consumption Value (2020-2031)
4.4 Asia-Pacific Ketorolac Tromethamine API Consumption Value (2020-2031)
4.5 South America Ketorolac Tromethamine API Consumption Value (2020-2031)
4.6 Middle East & Africa Ketorolac Tromethamine API Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
5.2 Global Ketorolac Tromethamine API Consumption Value by Type (2020-2031)
5.3 Global Ketorolac Tromethamine API Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
6.2 Global Ketorolac Tromethamine API Consumption Value by Application (2020-2031)
6.3 Global Ketorolac Tromethamine API Average Price by Application (2020-2031)

7 North America

7.1 North America Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
7.2 North America Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
7.3 North America Ketorolac Tromethamine API Market Size by Country
- 7.3.1 North America Ketorolac Tromethamine API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Ketorolac Tromethamine API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
8.2 Europe Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
8.3 Europe Ketorolac Tromethamine API Market Size by Country
- 8.3.1 Europe Ketorolac Tromethamine API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Ketorolac Tromethamine API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Ketorolac Tromethamine API Market Size by Region
- 9.3.1 Asia-Pacific Ketorolac Tromethamine API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Ketorolac Tromethamine API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
10.2 South America Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
10.3 South America Ketorolac Tromethamine API Market Size by Country
- 10.3.1 South America Ketorolac Tromethamine API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Ketorolac Tromethamine API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Ketorolac Tromethamine API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Ketorolac Tromethamine API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Ketorolac Tromethamine API Market Size by Country
- 11.3.1 Middle East & Africa Ketorolac Tromethamine API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Ketorolac Tromethamine API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Ketorolac Tromethamine API Market Drivers
12.2 Ketorolac Tromethamine API Market Restraints
12.3 Ketorolac Tromethamine API Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Ketorolac Tromethamine API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ketorolac Tromethamine API
13.3 Ketorolac Tromethamine API Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Ketorolac Tromethamine API Typical Distributors
14.3 Ketorolac Tromethamine API Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Ketorolac Tromethamine API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Ketorolac Tromethamine is the tromethamine salt of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac tromethamine, a non-selective inhibitor of the cyclooxygenases (COX), inhibits both COX-1 and COX-2 enzymes. This agent exerts its anti-inflammatory effect by preventing conversion of arachidonic acid to prostaglandins at inflammation site mediated through inhibition of COX-2, which is undetectable in most tissues but is up-regulated at the inflammation sites. Since COX-1 is expressed virtually in all tissues, inhibition of COX-1 enzyme by this agent prevents normal state production of prostaglandins, which plays housekeeping roles in the protection of the gastrointestinal tract, regulating renal blood flow, and functioning in platelet aggregation. As a result, inhibition of COX-1 is usually associated with adverse effects such as gastrointestinal toxicity and nephrotoxicity.
This report is a detailed and comprehensive analysis for global Ketorolac Tromethamine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ketorolac Tromethamine API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Ketorolac Tromethamine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Ketorolac Tromethamine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Ketorolac Tromethamine API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ketorolac Tromethamine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ketorolac Tromethamine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Farmak A.S, UQUIFA, Symed Labs Limited, Vasudha Pharma Chem Limited, Recordati, Smilax Laboratories Limited, Nishchem International Pvt. Ltd., Chromo Laboratories India Pvt Ltd, Renanpharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ketorolac Tromethamine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Ketorolac Tromethamine Capsules
Ketorolac Tromethamine Tablets
Ketorolac Tromethamine Injection
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Farmak A.S
UQUIFA
Symed Labs Limited
Vasudha Pharma Chem Limited
Recordati
Smilax Laboratories Limited
Nishchem International Pvt. Ltd.
Chromo Laboratories India Pvt Ltd
Renanpharma
Zhejiang Charioteer Pharmaceutical Co.,Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketorolac Tromethamine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ketorolac Tromethamine API, with price, sales quantity, revenue, and global market share of Ketorolac Tromethamine API from 2020 to 2025.
Chapter 3, the Ketorolac Tromethamine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketorolac Tromethamine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ketorolac Tromethamine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ketorolac Tromethamine API.
Chapter 14 and 15, to describe Ketorolac Tromethamine API sales channel, distributors, customers, research findings and conclusion.

Buy now